Who should pay for the continuity of post-trial health care treatments?-Reference-Cited by-同舟云学术

Who should pay for the continuity of post-trial health care treatments?

Published:2019-06-03 Issue:1 Volume:18 Page:
ISSN:1475-9276
Container-title:International Journal for Equity in Health
language:en
Short-container-title:Int J Equity Health

Author:

Iunes Roberto,Uribe Manuela Villar,Torres Janet Bonilla,Garcia Marina Morgado,Alvares-Teodoro Juliana,de Assis Acurcio Francisco,Junior Augusto Afonso Guerra

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12939-019-0919-0.pdf

Reference17 articles.

1. Ciaranello AL, Walensky RP, Sax PE, Chang Y, Freedberg KA, Weissman JS. Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents. HIV Clin Trials. 2009;10(1):13–24 Available from: https://doi.org/10.1310/hct1001-013 .

2. Cho HL, Danis M, Grady C. Post-trial responsibilities beyond post-trial access. Lancet. 2018;39:1478–9.

3. Cohen ERM, O’Neill JM, Joffres M, Upshur REG, Mills E. Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials. Dev World Bioeth. 2009;9(2):74–80 Available from: https://doi.org/10.1111/j.1471-8847.2008.00233.x .

4. Dainesi SM. Fornecimento de medicamentos pós pesquisa. São Paulo: Tese (doutorado) Faculdade de Medicina da Universidade de São Paulo; 2011. Available from: file:///C:/users/user/downloads/SoniaMansoldoDainesi.pdf

5. Dainesi SM, Goldnaum M. Fornecimento de medicamento investigacional após o fim da pesquisa clínica –Revisão da literatura e das diretrizes nacionais e internacionais. Rev Assoc Med Bras. 2011;57(6):710–6 Available from: https://doi.org/10.1590/s0104-42302011000600021 .

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Need for greater post-trial support for clinical trial participants assessing high-risk, irreversible treatments;Journal of Medical Ethics;2024-06-04

2. When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research;Neuroethics;2023-11-06

3. Post-trial provisions in the Declaration of Helsinki: a watered-down principle that needs to be strengthened;Journal of the Royal Society of Medicine;2022-11

4. Acesso a medicamentos para doenças raras no pós-estudo: revisão integrativa;Revista Bioética;2022-09

5. Acceso a medicamentos para enfermedades raras en el posestudio: una revisión integradora;Revista Bioética;2022-09